Hologic Inc. [NASDAQ: HOLX] stock went on a downward path that fall over -8.07% on Friday, amounting to a one-week price decrease of less than -5.41%. The company report on February 19, 2021 that New Research Published in the Journal of the American College of Radiology Confirms Black Women More Likely to Receive Inferior Breast Cancer Screening Than White Women, Points to Need for Stronger Breast Health Equity Reform.
Review of more than 800,000 mammograms reveals Black women less likely to be screened via digital breast tomosynthesis, despite the technology being proven superior to traditional mammography for all women.
A comprehensive study published in the Journal of the American College of Radiology (JACR) found racial disparities in the utilization of mammography screening overall, and specifically for digital breast tomosynthesis (DBT).
Over the last 12 months, HOLX stock rose by 43.62%. The one-year Hologic Inc. stock forecast points to a potential upside of 14.51. The average equity rating for HOLX stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $21.21 billion, with 258.61 million shares outstanding and 255.98 million shares in the current float. Compared to the average trading volume of 1.90M shares, HOLX stock reached a trading volume of 5375827 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Hologic Inc. [HOLX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOLX shares is $88.54 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOLX stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Hologic Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on November 20, 2020. While these analysts kept the previous recommendation, Needham raised their target price from $78 to $88. The new note on the price target was released on November 05, 2020, representing the official price target for Hologic Inc. stock. Previously, the target price had yet another raise to $64, while Cowen analysts kept a Outperform rating on HOLX stock.
The Average True Range (ATR) for Hologic Inc. is set at 2.96, with the Price to Sales ratio for HOLX stock in the period of the last 12 months amounting to 4.68. The Price to Book ratio for the last quarter was 5.99, with the Price to Cash per share for the same quarter was set at 3.10. Price to Free Cash Flow for HOLX in the course of the last twelve months was 15.44 with Quick ratio for the last quarter at 2.10.
HOLX Stock Performance Analysis:
Hologic Inc. [HOLX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.41. With this latest performance, HOLX shares dropped by -1.98% in over the last four-week period, additionally plugging by 12.90% over the last 6 months – not to mention a rise of 43.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOLX stock in for the last two-week period is set at 41.20, with the RSI for the last a single of trading hit 33.87, and the three-weeks RSI is set at 45.49 for Hologic Inc. [HOLX]. The present Moving Average for the last 50 days of trading for this stock 77.14, while it was recorded at 81.39 for the last single week of trading, and 66.14 for the last 200 days.
Insight into Hologic Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Hologic Inc. [HOLX] shares currently have an operating margin of +30.47 and a Gross Margin at +58.62. Hologic Inc.’s Net Margin is presently recorded at +29.53.
Return on Total Capital for HOLX is now 20.76, given the latest momentum, and Return on Invested Capital for the company is 21.33. Return on Equity for this stock inclined to 46.27, with Return on Assets sitting at 16.35. When it comes to the capital structure of this company, Hologic Inc. [HOLX] has a Total Debt to Total Equity ratio set at 116.34. Additionally, HOLX Total Debt to Total Capital is recorded at 53.78, with Total Debt to Total Assets ending up at 43.74. Long-Term Debt to Equity for the company is recorded at 103.39, with the Long-Term Debt to Total Capital now at 47.79.
Reflecting on the efficiency of the workforce at the company, Hologic Inc. [HOLX] managed to generate an average of $191,813 per employee. Receivables Turnover for the company is 4.50 with a Total Asset Turnover recorded at a value of 0.55.Hologic Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.50.
HOLX Stock EPS
With the latest financial reports released by the company, Hologic Inc. posted 0.57/share EPS, while the average EPS was predicted by analysts to be reported at 0.57/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOLX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hologic Inc. go to 10.47%.
Hologic Inc. [HOLX] Insider Position Details
There are presently around $17,979 million, or 98.20% of HOLX stock, in the hands of institutional investors. The top three institutional holders of HOLX stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 39,270,192, which is approximately -4.918% of the company’s market cap and around 1.00% of the total institutional ownership; VANGUARD GROUP INC, holding 27,548,047 shares of the stock with an approximate value of $2.09 billion in HOLX stocks shares; and FMR LLC, currently with $2.0 billion in HOLX stock with ownership of nearly 31.043% of the company’s market capitalization.
Positions in Hologic Inc. stocks held by institutional investors increased at the end of January and at the time of the January reporting period, where 316 institutional holders increased their position in Hologic Inc. [NASDAQ:HOLX] by around 19,197,199 shares. Additionally, 266 investors decreased positions by around 21,541,437 shares, while 80 investors held positions by with 196,795,626 shares. The mentioned changes placed institutional holdings at 237,534,262 shares, according to the latest SEC report filing. HOLX stock had 109 new institutional investments in for a total of 3,543,839 shares, while 44 institutional investors sold positions of 4,020,603 shares during the same period.